The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….
Recently, visitors to Oxford’s Westgate Centre were able to learn about the world-class healthcare research taking place in the city. The annual Biomedical Research Centre (BRC) Open Day, hosted by…
Professor Rachel Upthegrove, who joins the University of Oxfords Department of Psychiatry and our BRC as Director Designate in August, has been made an MBE in the King’s Birthday Honours…
Dr Ludovica Griffanti is Associate Professor in the University of Oxford’s Department of Psychiatry and Alzheimer’s Association Research Fellow at the Wellcome Centre for Integrative Neuroimaging (WIN). Her research focuses on neuroimaging…
Recently, Oxford Academic Health Partners (OAHP) published a case study about the Brain Health Centre. The Oxford Brain Heath Centre is an integrated research and clinical environment dedicated to preparing clinical…
Come and join us for our BRC Open Day at the Westgate Centre in Oxford between 10am and 3.30pm on Thursday 30 May. The event – held jointly with Oxford…
The University of Oxford and Oxford Health Clinical Research Facility is part of country-wide trials to identify accurate and quick blood tests that can diagnose dementia. World-class research teams at Dementias…
Recently, the OH BRC held a Joint Equality Diversity and Inclusion (EDI) & Patient and Public Involvement Engagement and Participation (PPIEP) workshop in Oxford to discuss barriers to research participation,…
We are delighted to announce that Professor Rachel Upthegrove has been appointed as the new director designate and Senior Clinical Researcher of the Oxford Health Biomedical Research Centre (OH BRC)…
Alzheimer’s Disease is a type of dementia in which abnormal proteins, called beta-amyloid and tau, accumulate in the brain and damage nerve cells. People with Alzheimer’s Disease often have trouble…
Opportunity for research posts that align with the Mental Health Mission Work Packages, and Demonstrator sites. Deadline for application: 1 March 2024 Queries to MHM-capacity@manchester.ac.uk. MHM Work Packages Capacity development…
COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment trial (COBALT) The Memory & Cognition Research Delivery Team at Oxford Health NHS Foundation Trust are looking for participants for…
As part of a visit on Thursday 25 January 2004 to discuss the Oxford Health BRC (OH BRC) and further collaborative opportunities, the University of Surrey showcased their exceptional state-of-the-art…
More people with dementia across the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of…
Staff at Oxford Health NHS Foundation Trust are recruiting people with mild Alzheimer’s disease for a study that looks into the reasons for the decline in the ability to function…
Associate Head of Department for Research and Oxford Health Biomedical Research Centre (OH BRC) Theme lead for Molecular Targets Professor Paul Harrison outlines the research highlights of 2023 in this…
In recent months the core team at OH BRC has expanded and we would like to welcome our new colleagues to the team. Cora Reilly-McGeown Patient and Public Involvement, Engagement…
Researchers from a wide range of disciplines have been appointed to be the next cohort of NIHR Oxford Senior Research Fellows – seven mid-career researchers identified as having the potential to become future…
Plans for Warneford Park took a step forward as partners in the project signed a Conditional Option Agreement (COA) and Memorandum of Understanding (MOU), agreeing how they will work together…
This morning the Oxford Academic Health Partners (OAHP) published an interview with NIHR Oxford Health Biomedical Research Centre Director Prof John Geddes. In the interview, Prof Geddes discusses the NIHR…
